Trending Now
LATEST ARTICLES
The First Prescription Digital Therapeutic for Anxiety & Depression
Happify Health launched Ensemble, the first and only transdiagnostic prescription digital therapeutic for the treatment of patients who have Major Depressive Disorder (MDD) or...
Can AI Misread Your Press Release? Why Pharma Needs an AI-Ingestion Audit
AI tools are now reading pharmaceutical press releases faster than most humans. Large language models, medical AI assistants, and automated summarization systems scan earnings...
Designing for the Second Audience: Why Every Pharma Campaign Is Public by Default
A decade ago, pharmaceutical marketers could still treat healthcare professional campaigns as relatively private communications. Sales aids, physician emails, congress materials, and gated portals...
The End of the Funnel: Why HCP Decision-Making No Longer Follows a Linear Path
A physician reviews an AI-generated treatment summary between patient visits. Minutes later, an EHR alert recommends a different therapy based on payer data. By...
From Safety Updates to Brand Signals: Rethinking Risk Communication in Pharma Marketing
Trust has become one of the most valuable assets in pharmaceutical marketing. In 2026, a “Safety Update” no longer feels like a regulatory footnote...
Access Is the Message: Why Pharma Campaigns Must Lead with Affordability and Coverage
A prescription that never gets filled is one of the most expensive failures in pharmaceutical marketing. Brands can spend millions building awareness, educating physicians,...
Marketing for Machines: How AI Gatekeepers Are Reshaping Pharma Content Visibility
A physician asks an AI assistant for the latest treatment insights. Within seconds, the system summarizes clinical evidence, filters trusted sources, and recommends the...
Advisory Committees as Brand Moments: Preparing for Public Scientific Scrutiny
One tense question from an FDA panel member can erase months of carefully managed messaging. A hesitant executive response can trigger investor panic before...
Real-Time Evidence, Real-Time Marketing: Why Static Campaigns Are Becoming a Risk
Pharmaceutical marketing is entering a new era. In 2026, the pace of clinical evidence generation has accelerated so quickly that traditional campaign planning can...
Compounded vs. Branded vs. Generic: The New Battle for Patient Understanding
The 2026 GLP-1 shortage changed more than prescription availability. It changed how patients think about medicine itself. As shortages pushed consumers toward compounded alternatives,...
The Platform Problem: When Telehealth and Retail Own the Pharma Customer Experience
A patient wakes up with symptoms, opens a telehealth app, speaks with a clinician, receives a prescription, and schedules medication delivery within 20 minutes....
